ALLOGENEIC STEM CELL TRANSPLANTS IN NON-CONDITIONED RECIPIENTS

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20120269774A1
SERIAL NO

12442356

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Methods, cells, and compositions of matter are disclosed for performing stem cell transplants in patients that have not been previously immunosuppressed. Specific disclosed are methods of matching, methods of treating the stem cell graft, and use of engraftment-assisting cells and agents.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddressTotal Patents
XON CELLS, INC.GERMANTOWN, MD4

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Ichim, Thomas E San Diego, US 27 189
Riordan, Neil H Chandler, US 35 191

Cited Art Landscape

Patent Info (Count) # Cites Year
 
THERAPURE BIOPHARMA INC. (1)
* 6361998 Efficient culture of stem cells for the production of hemoglobin 3 1999
 
BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (1)
* 2003/0068,664 Measuring circulating therapeutic antibody, antigen and antigen/antibody complexes using elisa assays 15 2002
 
G. D. Searle & Co. (1)
* 5858347 Therapeutic methods using fusion proteins between interleukin-3 (IL-3) variants and other hematopoietic factors 47 1995
 
SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH (1)
* 2005/0026,854 Selective elimination of cd52and uses thereof 1 2004
 
BECTON, DICKINSON AND COMPANY (1)
* 5840580 Phenotypic characterization of the hematopoietic stem cell 58 1997
* Cited By Examiner

Patent Citation Ranking

Forward Cite Landscape

Patent Info (Count) # Cites Year
 
Other [Check patent profile for assignment information] (1)
* 2015/0209,404 CELLULAR BLOOD MARKERS FOR EARLY DIAGNOSIS OF ALS AND FOR ALS PROGRESSION 0 2015
 
Anthrogenesis Corporation (3)
* 8562973 Treatment of sarcoidosis using placental stem cells 3 2011
* 8969315 Enhancement of placental stem cell potency using modulatory RNA molecules 1 2011
* 2012/0230,959 ENHANCEMENT OF PLACENTAL STEM CELL POTENCY USING MODULATORY RNA MOLECULES 16 2011
 
ALLOSOURCE (4)
9358320 Multi-layer tissue patches 2 2011
9480549 Multi-layer tissue patches 0 2013
9616152 Multi-layer tissue systems and methods 0 2013
9446077 Fascia fibrous compositions and methods for their use and manufacture 0 2014
 
CELLERIX, S.A. (1)
* 2012/0027,730 USES OF MESENCHYMAL STEM CELLS 0 2009
* Cited By Examiner